Register / Log In

Drug-resistant disease re-emerge, gain strength


 

National report — Key concerns regarding infectious diseases with cutaneous manifestations include the strongyloidiasis parasite infection imageThis patient with strongyloidiasis, presented with dermatologic symptoms including a creeping eruption. (Photo: CDC)expanding reach of infections formerly thought rare and exotic, experts say. Meanwhile, they add, some infections rarely seen stateside in recent years are resurging.

Expanding global travel fuels the spread of many of these diseases, say Stephen K. Tyring, M.D., Ph.D., M.B.A., and Casey Carlos, M.D., Ph.D. Dr. Tyring is clinical professor of dermatology, microbiology/molecular genetics and internal medicine at the University of Texas Health Science Center, and medical director of the Center for Clinical Studies in Houston. Dr. Carlos is assistant professor of internal medicine in the division of dermatology, University of California, San Diego.

 

FDA suggests approval of two antibiotics for skin infections

Going viral

Dr. Tyring also blames complacency. With fewer parents getting their children vaccinated for measles, for example, he says that 2013 saw more measles cases in the United States (175 as of Dec. 6) than any prior year of the 21st century.

Accordingly, he says, “Infectious diseases of the 20th century such as measles are not eradicated. And some diseases that were very rare in the United States at the beginning of the 21st century are coming back with a vengeance.” Therefore, he says that for every disease for which there is a vaccine, “It’s important that people get vaccinated.”

Next: Hepatitis B is emerging in the U.S.

 

 

More on skin infections

FDA approves dalbavancin for adults with acute skin infections

FDA approves tedizolid phosphate for acute skin infections

A new area of research may help in the development of more effective topical products to counteract polycyclic aromatic hydrocarbons, a result of air pollution which impacts skin aging.

Cosmetic concerns are important to many of our patients. Among the difficulties faced by consumers is the blitz of advertising of new and presumably revolutionary products that can rejuvenate and preserve the youthful appearance of the skin. Many products make what sound like medical claims about the efficacy of these agents. Norman Levine, M.D., asked Zoe Draelos, M.D., the foremost authority on this subject, to discuss these issues with us.

Are you interested in learning how to promote your dermatology practice on Twitter? Compared to other social networks, Twitter is one of the simplest and most straightforward platforms you could ever use.

Purpura, whether after trauma or an aesthetic procedure, is undesirable to patients. The ecchymoses can last for up to two weeks, and dyspigmentation can persist even longer.

The commercialization of ingenol mebutate (Picato, LEO Pharma) a medication that is currently approved in the United States and many other countries for the treatment of actinic keratosis, is an example of how enthusiasm and commitment can drive innovation, a LEO Pharma general manager says.